Related Experiment Video

Updated: Jun 10, 2026

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
04:55

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

Published on: May 26, 2023

Pediatric emergency research networks: a global initiative in pediatric emergency medicine

Terry P Klassen1, Jason Acworth, Liza Bialy

  • 1Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.

Pediatric Emergency Care
|July 27, 2010
PubMed

Insights

The Pediatric Emergency Research Network (PERN) aims to improve global child health outcomes through collaborative research. The network is developing an H1N1 risk factor study and planning future international projects.

Area of Science:

  • Pediatric Emergency Medicine
  • Global Health Research
  • Clinical Network Collaboration

Background:

  • Established pediatric emergency medicine research networks convened to foster collaboration.
  • Networks shared missions, infrastructure, and research contributions.
  • Discussions focused on improving network effectiveness and global child health.

Purpose of the Study:

  • To establish a global pediatric emergency research network (PERN).
  • To share best practices and improve research network effectiveness.
  • To explore collaborative research for acutely ill and injured children worldwide.

Main Methods:

  • An inaugural meeting in October 2009 included 18 delegates from five major international pediatric emergency medicine research networks.
  • Networks represented included those from the United States, Canada, Australia/New Zealand, and Europe/Middle East.
  • The meeting facilitated sharing of network missions, goals, infrastructure, and research contributions.

Main Results:

  • The meeting highlighted a shared commitment to high-quality research for improving pediatric health outcomes globally.
  • PERN is finalizing a protocol for a retrospective study on H1N1 risk factors.
  • A common desire for research dissemination to enhance child health was evident.

Conclusions:

  • PERN members will present their H1N1 initiative at the International Conference on Emergency Medicine.
  • Future global collaborations are planned for all five networks in late 2010.
  • The network aims to promote quality of care for acutely ill and injured children worldwide.
Abstract

More Related Videos

Neonatal Pial Surface Electroporation06:22

Neonatal Pial Surface Electroporation

Published on: May 7, 2014

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...